Background Stroke volume is an established echocardiographic marker but has not been widely studied in patients with ...

In contrast to HF with reduced EF, where events (e.g., myocardial infarction) often signal the onset of cardiac dysfunction and symptoms, this is not the case in HF with normal EF, which starts ...

Please provide your email address to receive an email when new articles are posted on . Cumulative exposure to increased BP from early adulthood on may influence right ventricular dysfunction in ...

Patients with either systolic (HFrEF) or diastolic (HFpEF) heart failure usually present in the same way. Common signs and symptoms include the following: worsening fatigue; dyspnea on exertion, which ...

Cardiomyopathy is the leading cause of mortality in patients with DMD. Compared with their healthy counterparts, patients with DMD — including those with preserved left ventricular ejection fraction ...

Heart failure sounds alarming—and rightfully so. Yet approximately 6.5 million Americans currently live with this condition, many with the specific variant called systolic heart failure, and a ...

Please provide your email address to receive an email when new articles are posted on . Cardiomyopathy in Duchenne muscular dystrophy possesses a unique pathophysiology. Integrated wall stress can be ...

ENTRESTO The FDA has approved Entresto for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged 1 year and older. The Food and Drug ...

A routine physical examination does not allow diagnosing systolic or diastolic LV dysfunction in the preclinical phase (stage B). Similarly, a physical examination cannot accurately characterize the ...